State Street Corp Viridian Therapeutics, Inc.\De Transaction History

State Street Corp

$2.41 Trillion
Q3 2024

A detailed history of State Street Corp transactions in Viridian Therapeutics, Inc.\De stock. As of the latest transaction made, State Street Corp holds 2,379,774 shares of VRDN stock, worth $47.1 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

2,379,774

Previous 2,772,379 14.16%

Holding current value

$47.1 Million

Previous $36.1 Million 50.1%

% of portfolio

0.0%

Previous 0.0%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$12.16 - $23.33 $4.77 Million - $9.16 Million	-392,605 Reduced 14.16%	2,379,774 $54.1 Million
Q2 2024 Aug 14, 2024	SELL	$11.6 - $17.26 $19.9 Million - $29.6 Million	-1,716,236 Reduced 38.24%	2,772,379 $36.1 Million
Q1 2024 May 15, 2024	BUY	$17.09 - $23.82 $30.4 Million - $42.4 Million	1,780,232 Added 65.73%	4,488,615 $78.6 Million
Q4 2023 Feb 14, 2024	SELL	$11.12 - $22.5 $2.59 Million - $5.25 Million	-233,307 Reduced 7.93%	2,708,383 $59 Million
Q3 2023 Nov 14, 2023	BUY	$15.16 - $24.7 $353,546 - $576,028	23,321 Added 0.8%	2,941,690 $45.1 Million
Q2 2023 Aug 14, 2023	BUY	$22.57 - $29.67 $11.7 Million - $15.3 Million	516,557 Added 21.51%	2,918,369 $69.4 Million
Q1 2023 May 15, 2023	BUY	$25.04 - $37.6 $13.5 Million - $20.3 Million	538,622 Added 28.91%	2,401,812 $61.1 Million
Q4 2022 Feb 14, 2023	BUY	$18.78 - $29.74 $12.9 Million - $20.4 Million	684,641 Added 58.09%	1,863,190 $54.4 Million
Q3 2022 Nov 15, 2022	BUY	$10.7 - $25.5 $7.74 Million - $18.4 Million	723,484 Added 158.98%	1,178,549 $24.2 Million
Q2 2022 Aug 15, 2022	BUY	$9.55 - $19.0 $3.72 Million - $7.39 Million	389,065 Added 589.49%	455,065 $5.27 Million
Q1 2022 May 16, 2022	BUY	$16.79 - $20.88 $536,591 - $667,303	31,959 Added 93.88%	66,000 $1.22 Million
Q4 2021 Feb 14, 2022	BUY	$15.65 - $21.5 $159,630 - $219,300	10,200 Added 42.78%	34,041 $673,000
Q3 2021 Nov 15, 2021	BUY	$10.69 - $18.2 $136,832 - $232,960	12,800 Added 115.93%	23,841 $392,000
Q2 2021 Aug 16, 2021	BUY	$14.34 - $18.67 $158,327 - $206,135	11,041 New	11,041 $202,000

Others Institutions Holding VRDN

# of Institutions

179

Shares Held

76.8M

Call Options Held

581K

Put Options Held

439K

View Full List

About Viridian Therapeutics, Inc.\DE

Ticker VRDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 39,888,900
Market Cap $789M
Description
Viridian Therapeutics, Inc., a biotechnology company, develops treatments for patients suffering from serious diseases. It develops VRDN-001, a humanized monoclonal anti-IGF-1R antibody that is in Phase 1/2 clinical trial for the treatment of thyroid eye disease (TED); VRDN-002, an IGF-1R antibody, which is in Phase 1 clinical trial; and VRDN-00...

More about VRDN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of State Street Corp, based on Form 13F filings with the SEC.

News

Stay updated on State Street Corp with notifications on news.

Account

State Street Corp Viridian Therapeutics, Inc.\De Transaction History